Anixa Biosciences secures Canadian patent allowance for ovarian‑cancer vaccine technology
The biotech firm announced that a Canadian patent office issued a notice of allowance, extending its international protection for the vaccine platform.
The biotech firm announced that a Canadian patent office issued a notice of allowance, extending its international protection for the vaccine platform.